Showing 38,361 - 38,380 results of 100,277 for search '(( 5 mean decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.82s Refine Results
  1. 38361

    Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism by Tobias Krämer (1350849)

    Published 2023
    “…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d<sup>9</sup> metalloradicals of the form [M(PR<sub>3</sub>)<sub>2</sub>]<sup>+</sup> (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr<sup>F</sup><sub>4</sub>]<sup>−</sup> (Ar<sup>F</sup> = 3,5-(CF<sub>3</sub>)<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) counterion. …”
  2. 38362

    Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism by Tobias Krämer (1350849)

    Published 2023
    “…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d<sup>9</sup> metalloradicals of the form [M(PR<sub>3</sub>)<sub>2</sub>]<sup>+</sup> (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr<sup>F</sup><sub>4</sub>]<sup>−</sup> (Ar<sup>F</sup> = 3,5-(CF<sub>3</sub>)<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) counterion. …”
  3. 38363

    Distribution of the ΔNPP-to-ΔMAT ratio in relation to MAT and MAP under the current climate. by Jumpei Toriyama (10156884)

    Published 2021
    “…<p>Results from (A) MIROC5 and (B) GFDL-CM3, based on the RCP2.6 scenario. …”
  4. 38364
  5. 38365
  6. 38366

    Image_2_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

    Published 2022
    “…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
  7. 38367

    Image_1_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

    Published 2022
    “…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
  8. 38368

    DataSheet1_Understanding the impact of radiotherapy fractionation on overall survival in a large head and neck squamous cell carcinoma dataset: a comprehensive approach combining m... by Igor Shuryak (337356)

    Published 2024
    “…Here we further investigated the validity of these conclusions by analyzing a large modern dataset on 3,346 HNSCC radiotherapy patients from the University Health Network in Toronto, Canada, where 42.5% of patients were also treated with chemotherapy.…”
  9. 38369
  10. 38370
  11. 38371
  12. 38372
  13. 38373
  14. 38374
  15. 38375
  16. 38376
  17. 38377
  18. 38378
  19. 38379
  20. 38380